SOLENO THERAPEUTICS INC (SLNO) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$190.4M

Net Income/Loss (FY2025)

$20.9M

Total Assets (FY2025)

$563.8M

Total Equity (FY2025)

$450.1M

Cash Flows from Operating Activities (FY2025)

$46.8M

Source: SOLENO THERAPEUTICS INC 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.